Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,349,490
+$604,704 QoQ
Shares Held
175,944
+167.2% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 168 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Derivatives in FULC
reported options exposure · as of Dec 31, 2024CallValue
$272,130
CallShares
57,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,099,505,720 across 232 Biotechnology names. FULC ranks #90 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in FULC
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,349,490 | 175,944 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $744,786 | 65,852 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $163,999 | 17,826 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $94,084 | 13,675 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $272,130 | 57,900 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $314,624 | 88,130 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $206,703 | 57,900 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $753,300 | 121,500 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $152,005 | 24,517 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $189,744 | 20,100 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $515,046 | 54,560 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $261,516 | 58,900 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $332,610 | 100,791 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $911,176 | 319,711 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $151,586 | 30,936 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $718,226 | 30,369 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $340,161 | 19,229 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $165,703 | 13,878 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||